ENTRY       D11708                      Drug
NAME        Givosiran sodium (JAN);
            Givlaari (TN)
PRODUCT     GIVLAARI (Alnylam Pharmaceuticals)
FORMULA     C524H694F16N173O316P43S6.43Na
EXACT_MASS  17280.5941
MOL_WEIGHT  17288.883
REMARK      Therapeutic category: 3999
            ATC code: A16AX16
            Chemical structure group: DG03084
            Product (DG03084): D11708<JP/US>
EFFICACY    Accumulation reduction (neurotoxic intermediates)
  DISEASE   Acute hepatic porphyria [DS:H00202]
  TYPE      RNA interference (RNAi) drug
COMMENT     Treatment of acute hepatic porphyria
TARGET      ALAS1 [HSA:211] [KO:K00643] (mRNA)
  PATHWAY   hsa00860(211)  Porphyrin metabolism
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AX Various alimentary tract and metabolism products
                 A16AX16 Givosiran
                  D11708  Givosiran sodium (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Givosiran
               D11708  Givosiran sodium (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D11708  Givosiran sodium (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Acyltransferases
                ALAS1
                 D11708  Givosiran sodium (JAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11708
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11708
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11708
DBLINKS     PubChem: 405226574
///
